IntelliSyn will be participating at the ChemOutsourcing meeting in New Jersey on September 19-21, 2016 and stop at Booth 108 to visit us.
IntelliSyn will be participating at the 252th ACS meeting in PHILADELPHIA, PA on August 21-25, 2016.
IntelliSyn Pharma is a proud sponsor of the IntelliSyn Research Excellence Award at the 99th Canadian Chemistry Conference and Exhibition (CSC2016; Symposia: Medicinal chemistry), June 5-9, 2016, Halifax, NS.
IntelliSyn Pharma is a proud sponsor of Professor David McMillan Symposium at McGill Chemistry Students Invited Lecture Series (MCSILS) on May 31, 2016.
IntelliSyn Pharma is a proud sponsor the Third International Symposium on C−H Activation (ISCHA3) that will take place at Université de Montréal (UdeM) from May 30 to June 2, 2016. The event will bring together a diverse consortium of world-class leaders who will present their latest research across the chemical sciences.
251th ACS San diego, CA – March 13-17, 2016. IntelliSyn will present on the following “Identification of inhibitors of HIF2a as modulators of the hypoxia response for the treatment of cancer – MEDI 305: Division of Medicinal Chemistry”
IntelliSyn will be at the 26th Quebec-Ontario Mini-Symposium on Bioorganic and Organic Chemistry held at UQAM University, Montreal, QC, CANADA.
IntelliSyn will be at the 2015 Sherbrooke International Life Science Summit in Sherbrooke, QC, CANADA
IntelliSyn will present on the following “Identification of inhibitors of oxygen-sensing transcriptional regulatory elements as modulators of the hypoxia response for the treatment of cancer” and “Development of highly potent, selective BET bromodomain inhibitors that are CNS penetrant and effective in rodent models of brain cancer”.
IntelliSyn will be at BIO 2015 – June 15-18, Philadelphia, PA and stop at Booth 715 to visit us.